Simple Summary The predictive value of existing venous thromboembolism risk assessment
models (RAMs) in lung cancer patients is still debated, and the design of new models …

The aim of the study was to investigate the prognostic significance of selected risk
assessment models (RAMs) for predicting venous thromboembolism (VTE) events in …

Aims The incidence of venous thromboembolism (VTE) in patients with lung cancer is
relatively high, and risk stratification models are vital for the targeted application of …

Venous thromboembolism (VTE) is a significant cause of mortality in patients with lung
cancer. Despite the availability of a wide range of anticoagulants to help prevent thrombosis …

Management of cancer-associated venous thromboembolism (VTE) is essential in treatment
selection and cancer prognosis. However, to date, there is no method to assess the risk of …

Background Patients with lung cancer are known to be at increased risk for venous
thromboembolism (VTE). Venous thromboembolism is associated with increased risk for …

Introduction Venous thromboembolism (VTE) is a common complication in patients with
cancer and has a determining role in the disease prognosis. The risk is significantly …

Background: Guidelines suggest the use of the Khorana score to select patients with solid
cancer receiving chemotherapy for thromboprophylaxis to prevent venous thromboembolism …

According to the most recent data from the National Cancer Center, venous
thromboembolism (VTE) has unsurprisingly become one of the most common complications …

Cancer patients are at higher risk for venous thromboembolism (VTE). Several risk
assessment models (RAM), including the Khorana and COMPASS-CAT, were developed to …